PMID: 1134886 Cairney DG, Beckwith HK, Al-Hourani K, Eddleston M, Bateman DN, Dear JW
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy

The Connection Between Oxidative Stress and Heart Health Oxidative stress is a major contributor to the development of cardiovascular diseases (CVD), including hypertension, atherosclerosis, and heart failure
2016, Article ID 4389410, 14 pages, 2016
Its a modified version of the first 29 amino acids of Growth Hormone Releasing Hormone (GHRH) the signal your hypothalamus sends to tell the pituitary to release GH
Fake products usually: Offer unusually low prices Lack proper printing quality Have no verification panel Show unclear batch or expiry details If the price looks too good to be true, it usually is